Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)
Brazil flag Brazil · Delayed Price · Currency is BRL
77.00
-0.76 (-0.98%)
Last updated: Apr 28, 2026, 10:52 AM GMT-3

Alnylam Pharmaceuticals Statistics

Total Valuation

BVMF:A1LN34 has a market cap or net worth of BRL 201.64 billion. The enterprise value is 201.94 billion.

Market Cap 201.64B
Enterprise Value 201.94B

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date Apr 30, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +5.51%
Shares Change (QoQ) -0.78%
Owned by Insiders (%) 0.37%
Owned by Institutions (%) 98.42%
Float 132.07M

Valuation Ratios

The trailing PE ratio is 116.68 and the forward PE ratio is 31.16.

PE Ratio 116.68
Forward PE 31.16
PS Ratio 9.86
PB Ratio 46.39
P/TBV Ratio 46.39
P/FCF Ratio 78.66
P/OCF Ratio 69.85
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 63.92, with an EV/FCF ratio of 78.78.

EV / Earnings 116.86
EV / Sales 10.87
EV / EBITDA 63.92
EV / EBIT 80.49
EV / FCF 78.78

Financial Position

The company has a current ratio of 2.76, with a Debt / Equity ratio of 3.76.

Current Ratio 2.76
Quick Ratio 2.51
Debt / Equity 3.76
Debt / EBITDA 4.70
Debt / FCF 6.38
Interest Coverage 1.99

Financial Efficiency

Return on equity (ROE) is 73.28% and return on invested capital (ROIC) is 86.03%.

Return on Equity (ROE) 73.28%
Return on Assets (ROA) 6.81%
Return on Invested Capital (ROIC) 86.03%
Return on Capital Employed (ROCE) 14.33%
Weighted Average Cost of Capital (WACC) 6.50%
Revenue Per Employee 8.18M
Profits Per Employee 691,247
Employee Count 2,500
Asset Turnover 0.81
Inventory Turnover 8.46

Taxes

In the past 12 months, BVMF:A1LN34 has paid 51.80 million in taxes.

Income Tax 51.80M
Effective Tax Rate 2.91%

Stock Price Statistics

The stock price has increased by +8.87% in the last 52 weeks. The beta is 0.38, so BVMF:A1LN34's price volatility has been lower than the market average.

Beta (5Y) 0.38
52-Week Price Change +8.87%
50-Day Moving Average 102.11
200-Day Moving Average 97.98
Relative Strength Index (RSI) 29.66
Average Volume (20 Days) 7,052

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.00

Income Statement

In the last 12 months, BVMF:A1LN34 had revenue of BRL 20.46 billion and earned 1.73 billion in profits. Earnings per share was 12.83.

Revenue 20.46B
Gross Profit 16.70B
Operating Income 2.76B
Pretax Income 1.78B
Net Income 1.73B
EBITDA 3.07B
EBIT 2.76B
Earnings Per Share (EPS) 12.83

Balance Sheet

The company has 16.02 billion in cash and 16.35 billion in debt, giving a net cash position of -332.21 million.

Cash & Cash Equivalents 16.02B
Total Debt 16.35B
Net Cash -332.21M
Net Cash Per Share n/a
Equity (Book Value) 4.35B
Book Value Per Share 32.84
Working Capital 14.23B

Cash Flow

In the last 12 months, operating cash flow was 2.89 billion and capital expenditures -323.30 million, giving a free cash flow of 2.56 billion.

Operating Cash Flow 2.89B
Capital Expenditures -323.30M
Depreciation & Amortization 278.06M
Net Borrowing -2.73B
Free Cash Flow 2.56B
FCF Per Share n/a

Margins

Gross margin is 81.64%, with operating and profit margins of 13.51% and 8.45%.

Gross Margin 81.64%
Operating Margin 13.51%
Pretax Margin 8.70%
Profit Margin 8.45%
EBITDA Margin 15.00%
EBIT Margin 13.51%
FCF Margin 12.53%

Dividends & Yields

BVMF:A1LN34 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.51%
Shareholder Yield -5.51%
Earnings Yield 0.86%
FCF Yield 1.27%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BVMF:A1LN34 has an Altman Z-Score of 6.35 and a Piotroski F-Score of 5.

Altman Z-Score 6.35
Piotroski F-Score 5